153 related articles for article (PubMed ID: 12888182)
1. S100B and response to treatment in major depression: a pilot study.
Arolt V; Peters M; Erfurth A; Wiesmann M; Missler U; Rudolf S; Kirchner H; Rothermundt M
Eur Neuropsychopharmacol; 2003 Aug; 13(4):235-9. PubMed ID: 12888182
[TBL] [Abstract][Full Text] [Related]
2. The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression.
Yang K; Xie GR; Hu YQ; Mao FQ; Su LY
J Neural Transm (Vienna); 2008 Dec; 115(12):1687-94. PubMed ID: 18982242
[TBL] [Abstract][Full Text] [Related]
3. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment.
Hetzel G; Moeller O; Evers S; Erfurth A; Ponath G; Arolt V; Rothermundt M
Psychopharmacology (Berl); 2005 Mar; 178(2-3):161-6. PubMed ID: 15316717
[TBL] [Abstract][Full Text] [Related]
4. S100B is increased in mood disorders and may be reduced by antidepressive treatment.
Schroeter ML; Abdul-Khaliq H; Diefenbacher A; Blasig IE
Neuroreport; 2002 Sep; 13(13):1675-8. PubMed ID: 12352625
[TBL] [Abstract][Full Text] [Related]
5. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
[TBL] [Abstract][Full Text] [Related]
6. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis.
Shi Y; Luan D; Song R; Zhang Z
Eur Neuropsychopharmacol; 2020 Dec; 41():40-51. PubMed ID: 32980240
[TBL] [Abstract][Full Text] [Related]
7. Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot study.
Petzold A; Green AJ; Keir G; Fairley S; Kitchen N; Smith M; Thompson EJ
Crit Care Med; 2002 Dec; 30(12):2705-10. PubMed ID: 12483062
[TBL] [Abstract][Full Text] [Related]
8. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point.
Rainey T; Lesko M; Sacho R; Lecky F; Childs C
Resuscitation; 2009 Mar; 80(3):341-5. PubMed ID: 19150161
[TBL] [Abstract][Full Text] [Related]
9. Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
Zhang XY; Xiu MH; Chen DC; Zhu FY; Wu GY; Haile CN; Lu L; Kosten TA; Kosten TR
J Psychiatr Res; 2010 May; 44(7):429-33. PubMed ID: 19932492
[TBL] [Abstract][Full Text] [Related]
10. Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression.
Dietrich DE; Hauser U; Peters M; Zhang Y; Wiesmann M; Hasselmann M; Rudolf S; Jüngling O; Kirchner H; Münte TF; Arolt V; Emrich HM; Johannes S; Rothermundt M
Neurosci Lett; 2004 Jan; 354(1):69-73. PubMed ID: 14698484
[TBL] [Abstract][Full Text] [Related]
11. Serum markers support disease-specific glial pathology in major depression.
Schroeter ML; Abdul-Khaliq H; Krebs M; Diefenbacher A; Blasig IE
J Affect Disord; 2008 Dec; 111(2-3):271-80. PubMed ID: 18430474
[TBL] [Abstract][Full Text] [Related]
12. S100B serum levels and word memory processing in remitted major depression as reflected by brain potentials.
Zhang Y; Rothermundt M; Peters M; Wiesmann M; Hoy L; Arolt V; Emrich HM; Dietrich DE
Neuropsychobiology; 2009; 59(3):172-7. PubMed ID: 19468240
[TBL] [Abstract][Full Text] [Related]
13. Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms.
Schmitt A; Bertsch T; Henning U; Tost H; Klimke A; Henn FA; Falkai P
Schizophr Res; 2005 Dec; 80(2-3):305-13. PubMed ID: 15964742
[TBL] [Abstract][Full Text] [Related]
14. Circulating cerebral S100B protein is associated with depressive symptoms following myocardial infarction.
Tulner DM; Smith OR; de Jonge P; van Melle JP; Slomp J; Storm H; Quere M; den Boer JA; Honig A; Korf J
Neuropsychobiology; 2009; 59(2):87-95. PubMed ID: 19325251
[TBL] [Abstract][Full Text] [Related]
15. Dynamic change of serum protein S100b and its clinical significance in patients with traumatic brain injury.
Chen DQ; Zhu LL
Chin J Traumatol; 2005 Aug; 8(4):245-8. PubMed ID: 16042873
[TBL] [Abstract][Full Text] [Related]
16. The roles of BDNF, S100B, and oxidative stress in interferon-induced depression and the effect of antidepressant treatment in patients with chronic viral hepatitis: a prospective study.
Cicek IE; Cicek E; Kayhan F; Uguz F; Erayman I; Kurban S; Yerlikaya FH; Kaya N
J Psychosom Res; 2014 Mar; 76(3):227-32. PubMed ID: 24529042
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study.
Machado-Vieira R; Lara DR; Portela LV; Gonçalves CA; Soares JC; Kapczinski F; Souza DO
Eur Neuropsychopharmacol; 2002 Jun; 12(3):269-72. PubMed ID: 12007679
[TBL] [Abstract][Full Text] [Related]
18. Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease.
Kim JK; Kim SG; Kim HJ; Song YR
Clin Biochem; 2012 Dec; 45(18):1573-7. PubMed ID: 22935566
[TBL] [Abstract][Full Text] [Related]
19. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
[TBL] [Abstract][Full Text] [Related]
20. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males.
da Rocha AB; Schneider RF; de Freitas GR; André C; Grivicich I; Zanoni C; Fossá A; Gehrke JT; Pereira Jotz G; Kaufmann M; Simon D; Regner A
Clin Chem Lab Med; 2006; 44(10):1234-42. PubMed ID: 17032136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
